Windsor, Ont., hospital postpones elective surgeries after Jan. 4 due to COVID surge Two UBC pharma stars recognized by the Order of Canada Zeposia: new oral treatment for relapsing-remitting multiple sclerosis Third oral sphingosine 1-phosphate receptor modulator to be marketed for MS in Canada. Ontario government facing criticism after COVID 19 shots slowed over holidays Favipiravir oral tablets being considered by Health Canada as a COVID-19 treatment Third drug to be filed for treatment of COVID-19 under Interim Order, following IV remdesivir and IV bamlanivimab. All COVID-19 vaccine clinics in Ontario set to reopen today after holiday closures Health Canada authorizes Moderna's COVID-19 vaccine ahead of holidays P.E.I. launching mental health and addictions app New prescription hypnotic for insomnia now available in Canada First marketed orexin receptor antagonist is approved for adults with difficulties in falling asleep and/or maintaining sleep. Ontario to receive 53,000 Moderna COVID-19 vaccine doses by end of December First Previous 1408 1409 1410 1411 1412 Next Last
